Atossa Therapeutics (MEX:ATOS) Pretax Margin % : % (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Atossa Therapeutics Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Atossa Therapeutics's Pre-Tax Income for the three months ended in Sep. 2024 was MXN-142.36 Mil. Atossa Therapeutics's Revenue for the three months ended in Sep. 2024 was MXN0.00 Mil. Therefore, Atossa Therapeutics's pretax margin for the quarter that ended in Sep. 2024 was %.

The historical rank and industry rank for Atossa Therapeutics's Pretax Margin % or its related term are showing as below:

MEX:ATOS's Pretax Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -148.6
* Ranked among companies with meaningful Pretax Margin % only.

Atossa Therapeutics Pretax Margin % Historical Data

The historical data trend for Atossa Therapeutics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atossa Therapeutics Pretax Margin % Chart

Atossa Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pretax Margin %

Get a 7-Day Free Trial

Atossa Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Pretax Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Atossa Therapeutics's Pretax Margin %

For the Biotechnology subindustry, Atossa Therapeutics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Atossa Therapeutics's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atossa Therapeutics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Atossa Therapeutics's Pretax Margin % falls into.

Atossa Therapeutics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Atossa Therapeutics's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-510.823	/	0
	=	%

Atossa Therapeutics's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	-142.361	/	0
	=	%

Atossa Therapeutics (MEX:ATOS) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Atossa Therapeutics Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Atossa Therapeutics's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Atossa Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atossa Therapeutics Inc (MEX:ATOS) » Definitions » Pretax Margin %

Comparable Companies

Traded in Other Exchanges

ATOS:USA YAG2:Germany

Address

107 Spring Street, Seattle, WA, USA, 98104

Website

https://www.atossatherapeutics.com

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.